10210 related articles for article (PubMed ID: 1438526)
1. Antitumor activity of siwenmycin: a novel anthracycline antibiotic.
Shen W; Chen R; Zhou M; Chen Y; Hu Q; Wang H; Wang Y; Jiao H
Pharmacology; 1992; 45(4):181-7. PubMed ID: 1438526
[TBL] [Abstract][Full Text] [Related]
2. [Experimental antimetastatic activity of aclarubicin].
Viadro MM; Terent'eva TG
Antibiot Khimioter; 1988 Nov; 33(11):845-8. PubMed ID: 3228327
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary mechanism studies of siwenmycin on the inhibition of nucleic acid syntheses].
Peng Y; Bao D; Wang L; Liu X; Ji X
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Jun; 24(2):139-42. PubMed ID: 7694898
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
6. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
8. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
9. Difference between the resistance mechanisms of aclacinomycin- and adriamycin-resistant P388 cell lines.
Dong J; Naito M; Tatsuta T; Seimiya H; Johdo O; Tsuruo T
Oncol Res; 1995; 7(5):245-52. PubMed ID: 8534930
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
[TBL] [Abstract][Full Text] [Related]
11. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
[TBL] [Abstract][Full Text] [Related]
12. [The antitumor activity of liposomal aclarubicin in vitro and in vivo].
Viadro MM; Navashin SM
Biull Eksp Biol Med; 1991 Nov; 112(11):523-5. PubMed ID: 1810495
[TBL] [Abstract][Full Text] [Related]
13. Eponemycin, a new antibiotic active against B16 melanoma. I. Production, isolation, structure and biological activity.
Sugawara K; Hatori M; Nishiyama Y; Tomita K; Kamei H; Konishi M; Oki T
J Antibiot (Tokyo); 1990 Jan; 43(1):8-18. PubMed ID: 2106503
[TBL] [Abstract][Full Text] [Related]
14. Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics.
Gomi K; Kobayashi E; Miyoshi K; Ashizawa T; Okamoto A; Ogawa T; Katsumata S; Mihara A; Okabe M; Hirata T
Jpn J Cancer Res; 1992 Jan; 83(1):113-20. PubMed ID: 1544867
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
17. Antitumor efficacies of aclacinomycin A by oral administration.
Tsukagoshi S; Tsuruo T; Yamori T; Iida H; Naganuma K; Sakurai Y
J Pharmacobiodyn; 1980 Oct; 3(10):532-6. PubMed ID: 6937651
[TBL] [Abstract][Full Text] [Related]
18. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
Burres NS; Sazesh S; Gunawardana GP; Clement JJ
Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
[TBL] [Abstract][Full Text] [Related]
20. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
